[CHRS] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 217.81%
YoY- 154.01%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 60,151 87,643 135,674 83,433 0 1,395 14,068 27.38%
PBT -50,150 -29,900 60,325 23,618 -43,685 -55,402 -70,150 -5.43%
Tax 6,137 5,758 1,294 51 6,012 5,938 -2,889 -
NP -56,287 -29,900 59,031 23,567 -43,638 -55,336 -69,967 -3.55%
Tax Rate - - -2.15% -0.22% - - - -
Total Cost 116,438 117,543 76,643 59,866 43,638 56,731 84,035 5.58%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -93.58 -34.12 43.51 28.25 0.00 -3,966.74 -497.35 -24.29%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.73 -0.40 0.83 0.34 -0.68 -1.08 -1.72 -13.30%
EPS Diluted -0.73 -0.40 0.70 0.32 -0.68 -1.08 -1.72 -13.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.